A General Warning Against Infringement Is Not Actual Notice of Infringement
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Before Dyk, Newman, and Wallach. Appeal from the Central District of California.
Summary: Specific charges of infringement by a specific accused product are required to provide actual notice under 35 U.S.C. § 287 and thereby support an award of pre-suit damages.
Patent owner Lubby Holdings LLC and its licensee Vaporous Technologies, Inc. (collectively, “Lubby”), sued Henry Chung for infringement. After a jury awarded damages, Chung moved for judgment as a matter of law arguing that Lubby was not entitled to damages for any infringement prior to the lawsuit because it failed to show marking of its own patented products or actual notice to Chung of his infringement, as 35 U.S.C. § 287 requires. The district court denied the motion and Chung appealed.
The Federal Circuit held that Lubby had not carried its burden to show marking or actual notice under § 287. Although the evidence at trial showed that Chung was aware of the patent’s issuance, and received a general warning not to infringe, Lubby provided no evidence that it communicated specific charges of infringement by a specific accused product prior to the lawsuit. Thus, the Federal Circuit held that Lubby was not entitled to pre-suit damages, and remanded for a new trial to determine the number of infringing products sold after the lawsuit was filed.
Editor: Paul Stewart
Written by: Jeremy Anapol
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…